A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

NCT06990880 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Prostate

Interventions

DRUG: GSK5458514

Sponsor

GlaxoSmithKline